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We found that the heat shock protein 90 (Hsp90) chaperone system
of the yeast Saccharomyces cerevisiae is greatly impaired in naa10Δ
cells, which lack the NatA Nα-terminal acetylase (Nt-acetylase) and
therefore cannot N-terminally acetylate a majority of normally
N-terminally acetylated proteins, including Hsp90 and most of its
cochaperones. Chk1, a mitotic checkpoint kinase and a client of
Hsp90, was degraded relatively slowly in wild-type cells but was
rapidly destroyed in naa10Δ cells by the Arg/N-end rule pathway,
which recognized a C terminus-proximal degron of Chk1. Diverse
proteins (in addition to Chk1) that are shown here to be targeted
for degradation by the Arg/N-end rule pathway in naa10Δ cells in-
clude Kar4, Tup1, Gpd1, Ste11, and also, remarkably, the main
Hsp90 chaperone (Hsc82) itself. Protection of Chk1 by Hsp90 could
be overridden not only by ablation of the NatA Nt-acetylase but also
by overexpression of the Arg/N-end rule pathway in wild-type cells.
Split ubiquitin-binding assays detected interactions between
Hsp90 and Chk1 in wild-type cells but not in naa10Δ cells. These
and related results revealed a major role of Nt-acetylation in the
Hsp90-mediated protein homeostasis, a strong up-regulation of the
Arg/N-end rule pathway in the absence of NatA, and showed that a
number of Hsp90 clients are previously unknown substrates of the
Arg/N-end rule pathway.
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Proteins called chaperones promote the in vivo protein foldingand counteract misfolding, maladaptive protein aggregation,
and other perturbations of proteostasis (1–4). Hsp90 is an ATP-
dependent chaperone system that mediates the conformational
maturation and stabilization of many proteins. Referred to as
Hsp90 clients, these proteins include kinases, transcriptional reg-
ulators, and many other proteins that comprise at least 20% of a
cellular proteome. The diversity of Hsp90 clients and the broad
range of processes that involve Hsp90 underlie its necessity for cell
viability in all eukaryotes (5–11). Cochaperones of the ∼90-kDa
Hsp90 comprise, in mammals, ∼30 distinct proteins. They partici-
pate in the delivery of clients to Hsp90 and contribute to related
processes, including ATP hydrolysis by Hsp90 (12). Because of its
ability to modulate protein conformations, the Hsp90 system can
either exacerbate or counteract the fitness-reducing effects of
mutations in cellular proteins. This property of Hsp90 affects the
standing genetic variation and thereby influences the impact of
natural selection on rates and directions of evolution (13, 14).
The N-end rule pathways comprise a set of proteolytic systems
whose unifying feature is their ability to recognize proteins con-
taining N-terminal (Nt) degradation signals called N-degrons,
thereby causing the degradation of these proteins by the proteasome
or autophagy in eukaryotes and by the proteasome-like ClpAP
protease in bacteria (Fig. 1) (15–26). The main determinant of an
N-degron is a destabilizing Nt-residue of a protein. Many N-degrons
become active through their enzymatic Nt-acetylation, Nt-
formylation, Nt-deamidation, Nt-arginylation, or Nt-leucylation.
Studies over the last three decades have shown that all 20 amino
acids of the genetic code can act, in cognate sequence contexts, as
destabilizing Nt-residues. Consequently, many, possibly most, pro-
teins in a cell are conditionally short-lived N-end rule substrates,
either as full-length proteins or as protease-generated natural pro-
tein fragments (21, 27). Recognition components of N-end rule
pathways are called “N-recognins.” In eukaryotes, N-recognins are
E3 ubiquitin (Ub) ligases that can target N-degrons (Fig. 1).
Regulated degradation of proteins or their fragments by N-end
rule pathways has been shown to mediate a wide range of processes,
including the sensing of oxygen, nitric oxide (NO), heme, and short
peptides; the control of subunit stoichiometry in protein complexes;
the elimination of misfolded proteins; the degradation of proteins
retrotranslocated to the cytosol from other compartments; the reg-
ulation of apoptosis and repression of neurodegeneration; the reg-
ulation of DNA repair, transcription, replication, and chromosome
cohesion/segregation; the regulation of G proteins, cytoskeletal
proteins, autophagy, gluconeogenesis, peptide import, meiosis, im-
munity, circadian rhythms, fat metabolism, cell migration, cardio-
vascular development, spermatogenesis, and neurogenesis; the
functioning of organs, including the brain, muscle, testis, and pan-
creas; and the regulation of leaf and shoot development, oxygen/NO
sensing, and many other processes in plants (refs. 15–17, 21–24, 28,
and the references therein).
Eukaryotes contain three N-end rule pathways. One of them, the
Arg/N-end rule pathway, targets unacetylated Nt-residues (Fig. 1B)
(18, 29–31). N-terminal Arg, Lys, His, Leu, Phe, Tyr, Trp, Ile, and
Met (if Met is followed by a bulky hydrophobic residue) are directly
recognized by N-recognins (15, 27, 32). In contrast, N-terminal
Asn, Gln, Glu, and Asp (as well as Cys, under some conditions)
are destabilizing because of the enzymatic deamidation of
N-terminal Asn and Gln and the arginylation of N-terminal Asp,
Glu, and (oxidized) Cys (33–37).
In the yeast Saccharomyces cerevisiae, the Arg/N-end rule
pathway is mediated by the Ubr1 N-recognin, a 225-kDa RING-
type E3 Ub ligase and a part of the targeting complex comprising
the Ubr1–Rad6 and Ufd4–Ubc4/5 E3-E2 holoenzymes (Fig. 1B) (38).
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Two substrate-binding sites of Ubr1 recognize N-degrons, whereas its
other binding sites recognize internal degrons in proteins such as
Cup9 or a variety of misfolded proteins (39–43). Thus, physiological
substrates of the Arg/N-end rule pathway comprise not only proteins
bearing N-degrons but also proteins containing internal degrons.
Another N-end rule pathway is the Ac/N-end rule pathway. It
recognizes Nα-terminally acetylated (Nt-acetylated) residues (Fig.
1A) (20, 27, 28, 44). N-degrons and E3 Ub ligases of the Ac/N-end
rule pathway are called Ac/N-degrons and Ac/N-recognins, re-
spectively. At least 60% of S. cerevisiae proteins and ∼90% of
human proteins are cotranslationally and irreversibly Nt-acetylated
by ribosome-associated Nt-acetylases (Fig. 1A) (45, 46). In exam-
ined cases, the presence of the Nt-Ac group in a subunit of a
protein complex increases the thermodynamic stability of the
complex, because affinity-enhancing contacts by the Nt-Ac group
cause a slower dissociation of the Nt-acetylated subunit (as com-
pared with its unacetylated counterpart) from the rest of the
complex (47–50). Many, possibly most, Nt-acetylated proteins
contain Ac/N-degrons, whose regulation includes their steric
shielding in cognate protein complexes (44).
The third eukaryotic N-end rule pathway, the Pro/N-end rule
pathway, is mediated by the GID Ub ligase. Gid4, a subunit of
GID that functions as the Pro/N-recognin, targets proteins that
bear the N-terminal Pro residue or a Pro at position 2, in addi-
tion to adjoining (and also required) sequence motifs (Fig. 1C)
(21). Physiological substrates of the Pro/N-end rule pathway in-
clude gluconeogenic enzymes, which are long-lived in cells de-
prived of glucose but are selectively destroyed upon return to
glucose-replete conditions (21, 51, 52).
We show here that the yeast Hsp90 chaperone system is greatly
impaired in naa10Δ cells, which lack the NatA Nt-acetylase and
therefore cannot Nt-acetylate a majority of normally Nt-acetylated
proteins. By exploring this finding, we identified extensive con-
nections between Hsp90 and the Arg/N-end rule pathway. These
and related results revealed a major role of Nt-acetylation in the
Hsp90-mediated protein homeostasis, a strong up-regulation of
the Arg/N-end rule pathway in the absence of NatA, and also
showed that a number of Hsp90 clients are previously unknown
substrates of the Arg/N-end rule pathway.
Results
Promoter Reference Technique. Degradation assays used the pro-
moter reference technique (PRT) (Fig. 2 A and B) (21). In this
method, one measures, during a chase, the ratio of a test protein
to a long-lived reference protein, the mouse dihydrofolate reduc-
tase (DHFR). The reference protein and test proteins were
Fig. 1. The N-end rule pathways. N-terminal residues
at the top of the diagram are indicated by single-
letter abbreviations. Twenty DNA-encoded amino
acids are arranged to delineate three sets of
N-degrons in S. cerevisiae, corresponding to three
N-end rule pathways. N-terminal Met is cited twice,
because it can be recognized by the Ac/N-end rule
pathway (as Nt-acetylated N-terminal Met) and by the
Arg/N-end rule pathway (as unacetylated N-terminal
Met). N-terminal Cys is also cited twice, because it can
be recognized by the Ac/N-end rule pathway (as Nt-
acetylated Cys) and by the Arg/N-end rule pathway
(as an oxidized, Nt-arginylatable N-terminal Cys,
denoted as Cys* and formed in multicellular eukary-
otes but apparently not in unstressed S. cerevisiae).
(A) The Ac/N-end Rule pathway. (B) The Arg/N-end
rule pathway. (C) The Pro/N-end rule pathway. See
the Introduction for references and brief descriptions
of these pathways.














coexpressed on a low-copy plasmid from two identical PTDH3 pro-
moters containing additional DNA elements developed by others
(53). Once transcribed into an mRNA, these elements form 5′-RNA
aptamers that can bind to tetracycline (Tc), thereby repressing
translation of that mRNA in cis (Fig. 2B). This PRT design im-
proves degradation assays in two independent ways: by providing a
reference protein and by allowing chases that involve a gene-
specific (Tc-mediated) repression of translation.
Chk1 Kinase Is Short-Lived in naa10Δ Cells. This work began with a
finding about the S. cerevisiae mitotic checkpoint kinase Chk1
(SL-Chk1, bearing N-terminal Ser-Leu) (54). C-terminally flag-
tagged wild-type SL-Chk13f was relatively long-lived in wild-
type cells but became short-lived in naa10Δ (ard1Δ) cells, which
lacked the NatA Nt-acetylase (Fig. 2 C and E and SI Appendix,
Fig. S2 A, C, and D).
The accelerated degradation of SL-Chk13f in naa10Δ cells was
manifested, in part, by much lower prechase (time-zero) levels of
SL-Chk13f in these cells (Fig. 2 C and E and SI Appendix, Fig. S2
A, C, and D). 35S-pulse-chases with SL-Chk13f produced similar
results (SI Appendix, Fig. S2B). We could ascribe the decreased
prechase levels of SL-Chk13f in naa10Δ cells to its faster degra-
dation (rather than to a decreased synthesis of Chk1), inasmuch as
these assays used PRT and its built-in reference protein (Fig. 2B).
As shown earlier, prechase effects analogous to those in naa10Δ
vs. wild-type cells stem from the accelerated destruction of nascent
and/or newly formed proteins (15, 27, 44). This aspect of SL-
Chk13f degradation was particularly prominent in naa10Δ cells
(Fig. 2 C and E and SI Appendix, Fig. S2 A, C, and D).
The faster degradation of SL-Chk13f in naa10Δ cells was
NatA-specific: This effect was absent in naa20Δ cells (which
lacked the NatB Nt-acetylase) and in naa30Δ cells (which
lacked the NatC Nt-acetylase) (Fig. 2G). An ectopic ex-
pression of NatA (Naa10) in naa10Δ cells (monitored by an-
tibody to Naa10) restored the relative stability of SL-Chk13f
(Fig. 3A).
Fig. 2. The PRT and degradation of Chk1 in naa10Δ cells. (A and B) The PRT. See the main text for a discussion. (C) Lane 1, kDa markers. CHX-chases, using PRT
with wild-type SL-Chk13f, were performed at 30 °C for 0, 20, 60, and 120 min, with wild-type (lanes 2–5), naa10Δ (lanes 6–9), ubr1Δ (lanes 10–13), and naa10Δ
ubr1Δ (lanes 14–17) S. cerevisiae. Extracts were prepared from cells withdrawn at the indicated times of a chase. Proteins in an extract were fractionated by
SDS/PAGE, followed by immunoblotting with anti-flag and anti-HA antibodies. (D) As in C, but CHX-chases, with the SK-Chk13f mutant, were for 0, 1, and 2 h,
with wild-type (lanes 2–4), naa10Δ (lanes 5–7), ubr1Δ (lanes 8–10), and naa10Δ ubr1Δ (lanes 11–13) S. cerevisiae. (E and F) Quantification of data in C and D,
respectively. For curve designations, see the keys below the immunoblots in C and D. All degradation assays in this study were performed at least twice,
yielding results that differed by less than 10%. (G) As in C, but CHX-chases, with wild-type SL-Chk13f, were for 0, 1, and 2 h, with wild-type (lanes 2–4), naa10Δ
(lanes 5–7), naa20Δ (lanes 8–10), and naa30Δ (lanes 11–13) S. cerevisiae. In C, D, and G, lane 1 shows kDa markers and blue stars denote 25-, 37-, 50-, and
75-kDa proteins.
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Chk1 as a Substrate of the Arg/N-End Rule Pathway in naa10Δ Cells.
The E3 Ub ligases Ubr1 and Ufd4 are a part of the targeting ap-
paratus of the Arg/N-end rule pathway (Fig. 1B). Remarkably, the
ablation of either Ubr1 or Ufd4 abrogated the accelerated degra-
dation of SL-Chk13f in naa10Δ cells. SL-Chk13f was as stable in
ubr1Δ naa10Δ and ufd4Δ naa10Δ double mutants as it was in wild-
type cells, despite the absence of the NatA (Naa10) Nt-acetylase in
double mutants and in contrast to the rapid degradation of SL-
Chk13f in single-mutant naa10Δ cells (Figs. 2 C and E and SI
Appendix, Fig. S2 A, C, andD). As would be expected (Fig. 1B), the
degradation of SL-Chk13f required the proteasome (Fig. 4D).
Degradation of Chk1 in naa10Δ Cells Does Not Involve the Cup9
Regulon. Cup9, a transcriptional repressor of a regulon containing
∼50 genes, is conditionally destroyed by the Arg/N-end rule path-
way through an internal degron of Cup9 (39). It was conceivable
that the tripartite Cup9–Tup1–Ssn6 repressor complex (39) might
dissociate more rapidly in the absence of NatA-mediated Nt-
acetylation, because of the “affinity” effect of Nt-Ac groups (de-
scribed in the Introduction). This effect would lead to a faster
degradation of Cup9 by the Arg/N-end rule pathway in naa10Δ
cells and, consequently, to an induction of the Cup9 regulon, whose
functions are incompletely understood. We therefore asked
whether the faster degradation of SL-Chk13f in naa10Δ cells might
be mediated by the Arg/N-end rule pathway indirectly, through a
faster destruction of Cup9 and the resulting up-regulation of a
member of the Cup9 regulon (e.g., an uncharacterized Ub ligase)
that would accelerate the degradation of SL-Chk13f in naa10Δ
cells. This model was found to be incorrect, inasmuch as SL-Chk13f
remained relatively long-lived in cup9Δ cells, in which the
Cup9 regulon becomes derepressed (Fig. 4E) (39).
Endogenous Chk1 and Its Targeting by the Arg/N-End Rule Pathway.
To address the degradation of endogenous SL-Chk1, we
replaced the chromosomal CHK1 gene with a DNA segment that
expressed wild-type SL-Chk1 C-terminally tagged with myc (SL-
Chk19m) from the endogenous PCHK1 promoter. The prechase
(time-zero) level of SL-Chk19m in wild-type cells was ∼2.5-fold
lower than in ubr1Δ cells (which lacked the Arg/N-end rule
pathway), confirming that a large fraction of the endogenous SL-
Chk19m was destroyed by the Arg/N-end rule pathway in wild-
type cells (SI Appendix, Fig. S3 C and D). Moreover, the pre-
chase level of endogenous SL-Chk19m was further decreased in
naa10Δ cells, becoming ∼4.7-fold lower than in ubr1Δ cells (SI
Appendix, Fig. S3 C and D). These findings were qualitatively
similar to the results with (moderately) overexpressed SL-Chk13f
(Fig. 2 C and E and SI Appendix, Fig. S2 A, C, and D).
Degradation of Chk1 in naa10Δ Cells Does Not Involve an N-Degron.
Might a small unacetylated Nt-residue (such as Ser) followed by a
bulky hydrophobic residue (such as Leu) function, in the contexts
of SL-Chk13f and naa10Δ cells, as a previously unknown N-degron?
To address this question, we constructed position-1, 2 mutants of
SL-Chk13f. Both wild-type SL-Chk13f and its mutants SD-Chk13f
and SF-Chk13f were predicted substrates of the NatA Nt-acetylase.
In contrast, the SK-Chk13f and SR-Chk13f mutants were unlikely to
be Nt-acetylated in wild-type cells, because a position-2 basic res-
idue impedes Nt-acetylation in yeast. The PS-Chk13f and SP-Chk13f
mutants, which contained Pro at positions 1 and 2, respectively,
were not Nt-acetylated in wild-type cells (45).
The results with XZ-Chk13f proteins (X = S, P; Z = L, D, F, K,
R, P), including wild-type SL-Chk13f, were essentially indistin-
guishable. All these proteins were degraded relatively slowly in
Fig. 3. Degradation of Hsc82 by the Arg/N-end rule pathway in naa10Δ cells. (A) CHX-chases, using PRT (Fig. 2B), with wild-type SL-Chk13f, for 0, 1, and 2 h, with
naa10Δ S. cerevisiae carrying a high-copy plasmid that expressed Naa10 from the PGAL promoter. Lane 1, kDa markers. Blue stars denote 20-, 25-, 37-, 50-, and
75-kDa markers, respectively. Lanes 2–4 and 5–7, cells (containing vector alone) in glucose and galactose medium, respectively. Lanes 8–10 and 11–13 are as in
lanes 2–4 and 5–7, respectively, but with cells containing the PGAL-NAA10 plasmid. The presence of Naa10 was verified directly, using an affinity-purified antibody
to Naa10 (bands in lanes 11–13, above the bands of DHFR). (B) Immunoblotting-based comparison of the levels of endogenous (untagged) Ubr1 in wild-type
naa10Δ and ubr1Δ S. cerevisiae (with ubr1Δ cells as a negative control), using an affinity-purified antibody to Ubr1 (see the main text), with immunoblots of
tubulin as a loading control. Blue stars denote 50-, 75-, 100-, 150-, and 250-kDa markers, respectively. (C) Quantification of the data in B, with subtraction of the
background-level signal in lane 4 (ubr1Δ cells) and with the level of Ubr1 in wild-type cells taken as 100%. (D) Degradation of Hsc82 in naa10Δ cells. Blue stars
denote 25-, 37-, 50-, 75-, and 100-kDa markers, respectively. Tc-chases, using PRT (Fig. 2B) with wild-type Hsc823f, were for 0, 1, 2, and 4 h, with wild-type (lanes
2–5), naa10Δ (lanes 6–9), and ubr1Δ (lanes 10–13) S. cerevisiae. Extracts were prepared from cells withdrawn at the indicated times of a chase. Proteins in an
extract were fractionated by SDS/PAGE, followed by immunoblotting with anti-flag and anti-HA antibodies. (E) Quantification of data in D. For curve desig-
nations, see the keys below the immunoblot in D. All chases in this study were performed at least twice, yielding results that differed by less than 10%.














wild-type cells, became much shorter-lived in naa10Δ cells, and
required the Arg/N-end rule pathway for their degradation in
naa10Δ cells (Figs. 2 C–F and 4 A–C and SI Appendix, Fig. S2 E
and F). We concluded that XZ-Chk13f (X = S, P; Z = L, D, F, K,
R, P), including wild-type SL-Chk13f, were targeted by the Arg/
N-end rule pathway in naa10Δ cells through an internal degron,
which was largely inactive in wild-type cells (see below).
Hsp90 and Cochaperones as Substrates of the NatA Nt-Acetylase.
Approximately 60% of proteins in the S. cerevisiae proteome are
predicted substrates of NatA (Naa10) (SI Appendix, Fig. S1) (45).
A parsimonious explanation of the accelerated degradation of SL-
Chk13f in naa10Δ (NatA-lacking) cells is that in wild-type cells SL-
Chk13f is shielded from the Arg/N-end rule pathway by a protective
entity that becomes impaired in the absence of Nt-acetylation by
NatA. Given the moderate overexpression of SL-Chk13f in our
assays (Fig. 2B), a protective entity had to be relatively abundant.
The leading candidate was Hsp90, inasmuch as SL-Chk1 is a pu-
tative client of Hsp90 (55).
Hsc82 and Hsp82 are two similar S. cerevisiaeHsp90 chaperones
(5, 8). Remarkably, our survey of the yeast Hsp90 system showed
that not only Hsc82 and Hsp82, but also their cochaperones Aha1,
Cdc37, Cns1, Cpr6, Cpr7, Hch1, Pih1, Ppt1, Rvb1, Rvb2, Sba1,
Sse1, Sse2, Sti1, and Tah1 were either identified or predicted
substrates of the NatA Nt-acetylase (SI Appendix, Figs. S1 and S5).
A bias this high was, a priori, an unlikely finding, because only
∼60% of the S. cerevisiae proteome are either identified or pre-
dicted substrates of NatA (45). It is unknown whether the ob-
served near-exclusive preference for NatA by the Hsp90 system
(SI Appendix, Figs. S1 and S5) is functionally adaptive, i.e.,
whether this bias was caused by natural selection. The alternative
interpretation is that this pattern resulted largely from a “fluctu-
ation” in a quasi-neutral genetic drift. In either case, these results
(SI Appendix, Fig. S5) were consistent with the relevance of
Hsp90 to degradation of SL-Chk13f in naa10Δ cells (Fig. 2 C and E
and SI Appendix, Fig. S2 A, C, and D).
Faster Degradation of Chk1 in Cells Containing Lower Levels of Hsp90.
If destabilization of SL-Chk13f in naa10Δ cells is caused by a
lower Hsp90 activity, a decreased level of Hsp90 would be
expected to accelerate the degradation of SL-Chk13f in Naa10
+
cells. S. cerevisiae Hsp90 is encoded by the constitutive HCS82
and the stress-inducible HSP82, whose single nulls (but not a
double null) yield viable cells (8). Immunoblotting-based com-
parisons of the levels of Hsc82+Hsp82 in wild-type cells vs.
hsc82Δ, hsp82Δ, and other mutants are shown in SI Appendix,
Fig. S3 D and E. We also found that SL-Chk13f was indeed
destabilized in either hsc82Δ cells or hsp82Δ cells but not as
strongly as in naa10Δ cells (SI Appendix, Fig. S3 A and B).
Ablation of Hsp90 Cochaperones Can Destabilize Chk1.We also found
that SL-Chk13f was shorter lived in Naa10
+ cells lacking the
cochaperones Sba1, Sse1, Sti1, or Tah1 (SI Appendix, Fig. S6 A
and B). These assays used Tc-PRT chases (Fig. 2 A and B). Tc is at
most weakly toxic, in contrast to highly toxic cycloheximide
(CHX). The basal degradation of SL-Chk13f was faster in
Tc-chases than in CHX-chases (e.g., compare Fig. 2 C and E with
SI Appendix, Fig. S6C). The cause of this difference was traced to
the in vivo degradation of the Ubr1 N-recognin (a study of this
aspect of the Arg/N-end rule pathway is under way). Although
chases that used CHX (at present the standard translation in-
hibitor for degradation assays in the Ub field) produced results
qualitatively similar to those with Tc, all chases at later stages of
the present study were done using Tc, for the reason above.
Hsp90 Itself and Other Proteins as Substrates of Ubr1 in naa10Δ Cells.
We also examined other, quasi-randomly chosen non-Chk1 proteins
for their degradation in naa10Δ cells vs. ubr1Δ cells. The
Ubr1 targets thus identified were Kar4, a transcriptional regulator of
pheromone responses; Tup1, a transcriptional corepressor; Gpd1,
glycerol-3-phosphate dehydrogenase; Ste11, a kinase regulator of
pheromone responses; and also, remarkably, Hsc82, the main
Hsp90 chaperone (Fig. 3D and E and SI Appendix, Figs. S3 E and F,
S6D, and S7). Tup1 and Ste11 are clients of Hsp90 (56); Kar4 and
Gpd1 may also be Hsp90 clients; and Hsc82 is itself an Hsp90.
The illuminating result that the Hsp90 (Hsc82) chaperone
becomes vulnerable to the Arg/N-end rule pathway in naa10Δ
cells (Fig. 3 D and E, and SI Appendix, Fig. S7 C and D) was in
agreement with a technically independent finding, that the level
of Hsc82+Hsp82 in naa10Δ cells was approximately twofold
Fig. 4. Degradation of Chk1 mutants by the Arg/N-
end rule pathway. (A) As in Fig. 2D, but with the SF-
Chk13f mutant. CHX-chases, using PRT (Fig. 2B), with
SF-Chk13f, for 0, 1, and 2 h, with wild-type (lanes
2–4), naa10Δ (lanes 5–7), ubr1Δ (lanes 8–10), and
naa10Δ ubr1Δ (lanes 11–13) S. cerevisiae. Blue stars
are as in Fig. 2D. (B) As in A but with the SP-Chk13f
mutant. (C) As in A but with the PS-Chk13f mutant.
(D) Lanes 2–4, CHX-chase, using PRT (Fig. 2B), with
wild-type SL-Chk13f, for 0, 1, and 2 h, in pdr5Δ cells.
Lanes 5–7 are as in lanes 2–4 but in pdr5Δ naa10Δ
cells. Lanes 8–10 and 11–13 are as in lanes 2–4 and 5–
7, respectively, but in the presence of 50 μMMG132,
a proteasome inhibitor. The absence of the Pdr5
multidrug transporter was necessary to make S.
cerevisiae sensitive to MG132. Blue stars denote 20-,
25-, 37-, 50-, and 75-kDa markers. (E) CHX-chases,
using PRT (Fig. 2B), with wild-type SL-Chk13f, for 0,
1, and 2 h, with wild-type (lanes 2–4), naa10Δ (lanes
5–7), cup9Δ (lanes 8–10), naa10Δ cup9Δ (lanes 11–
13), and naa10Δ cup9Δ ubr1Δ (lanes 14–16) S. cer-
evisiae. Blue stars denote 25-, 37-, 50-, and 75-kDa
markers.
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lower than in wild-type cells (SI Appendix, Fig. S4 D and E).
Together, these findings strongly suggested that newly formed
Hsc82 and Hsp82 are themselves clients of mature Hsc82/Hsp82,
requiring the (unimpaired) Hsp90 system for their conforma-
tional maturation and protection from the Arg/N-end rule
pathway. The Ubr1-mediated degradation of Hsc82 (Fig. 3 D
and E and SI Appendix, Figs. S4 D and E and S7 C and D) would
account, at least in part, for the decreased protection, in naa10Δ
cells, of Hsp90 clients such as SL-Chk13f (Fig. 2 C and E).
As already observed with SL-Chk13f, one aspect of the Ubr1-
dependent patterns of degradation of Kar4, Tup1, Gpd1, Ste11,
and Hsc82 was a significant increase in the prechase (time-zero)
level of a test protein in ubr1Δ cells (which lacked the Arg/N-end
rule pathway), as compared with, e.g., naa10Δ cells. Particularly
clear examples of this increase were Hsc82, Ste11, and Gpd1
(Fig. 3 D and E and SI Appendix, Figs. S6D and S7).
A parsimonious interpretation of the relative flatness of decay
curves in some of these cases (e.g., SI Appendix, Fig. S6D), with
the major change being a time-zero (prechase) alteration, is that
“young” molecules of a protein (either cotranslationally or shortly
after translation) are particularly vulnerable to the Arg/N-end rule
pathway. The subsequent folding and quaternary structure for-
mation (for example, mature Gpd1 is a homodimer) would make
these proteins either partly or completely resistant to the Ubr1-
mediated degradation through the shielding of a cognate degron
and/or through a higher resistance to the unfolding of a targeted
protein by the 26S proteasome. Conformational maturation of the
above (and other) proteins can be partly reversible and takes
place, at least in part, through their (protective) interactions with
the Hsp90 system. Thus impairment of Hsp90 in naa10Δ cells
increases the vulnerability of some Hsp90 clients, such as condi-
tional Ubr1 substrates, to attacks by the Arg/N-end rule pathway.
An extensively analyzed precedent for the non–first-order
(nonexponential) degradation kinetics by the Arg/N-end rule
pathway was X–β-galactosidase (X–β-gal) bearing a destabilizing
N-terminal residue (18). These first (engineered) Arg/N-end rule
substrates were vulnerable to the targeting by Ubr1 cotrans-
lationally and/or shortly after translation. The subsequent
formation of an X–β-gal homotetramer led to the nearly (but
not quite) complete cessation of the degradation of a “ma-
ture” X–β-gal tetramer by the Arg/N-end rule pathway (15, 18, 19).
Later studies have shown that a non–first-order degradation kinetics
is also a frequent aspect of proteolysis by the Ub system at large,
resulting, primarily, from the same causes of time-dependent pro-
tein folding and formation of protein complexes (44, 57–59).
As shown below, Ubr1 recognizes an internal, C terminus-
proximal degron of SL-Chk1. It is likely (but remains to be verified)
that Kar4, Tup1, Gpd1, Ste11, and Hsc82 also bear Ubr1-specific
internal degrons (as distinguished from N-degrons). Overall, ∼60%
of 11 examined yeast proteins were identified as substrates of the
Arg/N-end rule pathway in naa10Δ cells. Given this percentage and
the quasi-random selection of proteins for these experiments, it is
possible, indeed likely, that roughly a half of natural Hsp90 clients,
i.e., ∼10% of the cellular proteome, will eventually be identified as
conditional (Hsp90 state-dependent) substrates of the Arg/N-end
rule pathway.
Overexpression of Ubr1–Ufd4 Destabilizes Chk1 in Wild-Type Cells.
Natural levels of Ubr1 are rate-limiting in the Arg/N-end rule
pathway (15). We therefore asked whether co-overexpression of
Ubr1 and Ufd4, two interacting Ub ligases of the Arg/N-end rule
pathway (Fig. 1B), might accelerate the degradation of SL-Chk13f
in wild-type cells, despite the presence of the NatA Nt-acetylase.
Remarkably, we found that they did so (Fig. 5 A and B). This result
strongly suggested that the rate of degradation of an Hsp90 client
such as SL-Chk13f is determined by a dynamic partitioning of SL-
Chk13f between a protected Hsp90-bound state and a “free” state
vulnerable to the Arg/N-end rule pathway.
The Endogenous Arg/N-End Rule Pathway Is Up-Regulated in naa10Δ
Cells. We also asked whether the Arg/N-end rule pathway might
become naturally up-regulated in naa10Δ cells, which exhibited
the accelerated degradation of SL-Chk13f (Fig. 2 C and E and SI
Appendix, Fig. S3 A, C, and D). We began by comparing, using an
affinity-purified antibody to S. cerevisiae Ubr1 (60), the levels of
Ubr1 in wild-type vs. naa10Δ cells, with ubr1Δ cells as a negative
control (Fig. 3 B and C). Despite the high sensitivity of this
antibody [it could detect, by immunoblotting, down to ∼2 ng of
Ubr1 (60)], the levels of endogenous Ubr1 in wild-type cells
[500–1,000 Ubr1 molecules per haploid cell in exponential
growth (38)] were low enough to make these measurements
technically challenging. Nevertheless, we reproducibly observed
an ∼2.5-fold increase of the endogenous, untagged Ubr1 in
naa10Δ cells as compared with wild-type cells (Fig. 3 B and C).
In a conceptually independent set of assays, we used X–β-gal
(in which X = His or Tyr) as Ub fusion-based reporters of the
Arg/N-end rule pathway (15, 18, 19). N-terminal His and Tyr are
recognized by Ubr1 through its type-1 site (this site binds to basic
Nt-residues) and type-2 site (this site binds to bulky hydrophobic
Nt-residues), respectively (Fig. 1B). In agreement with the higher
levels of Ubr1 in naa10Δ cells (Fig. 3 B and C), the degradation
of His–β-gal and Tyr–β-gal was much faster in naa10Δ cells than
in wild-type cells (see Fig. 7 C–E). A strong up-regulation of the
Arg/N-end rule pathway in the absence of NatA provides a
glimpse of still unexplored circuits that regulate the levels of
pathway’s components and the activity of this proteolytic system.
Mapping the Chk1 Degron by Degradation Assays. Having de-
termined that the targeting of SL-Chk13f did not involve an N-degron
(Figs. 2 C–F and 4 A–C, and SI Appendix, Fig. S2 E and F), we
mapped an internal degron of Chk1 by examining its
C-terminally truncated derivatives (SI Appendix, Fig. S8). Except
for SL-Chk11−5023f and SL-Chk1
1−465
3f , the truncated derivatives of
SL-Chk11−5273f could not be expressed in reference-based PRT
assays at readily detectable levels in either wild-type or ubr1Δ
cells (SI Appendix, Fig. S8), suggesting their rapid (and Ubr1-
independent) destruction, likely as the result of their misfolding.
The absence, in SL-Chk11−5023f , of only 25 C-terminal residues of
wild-type SL-Chk11−5273f abolished a decreased prechase level of
Chk1 in naa10Δ cells and also nearly sufficed to eliminate the
dependence of degradation on Ubr1 (SI Appendix, Fig. S6 A and
B). SL-Chk11−4653f yielded similar results, except that the effect of
Ubr1 was now completely gone (SI Appendix, Fig. S6 A and C).
Thus, a degron recognized by Ubr1 is located largely within the
last 25 residues of the 527-residue Chk1.
Mapping the Chk1 Degron by Two-Hybrid Binding Assays. We re-
cently used two-hybrid assays (61) to map the recognition of a
degron by its cognate E3 Ub ligase (21). Application of this
method to interactions between Chk1 and the Ubr1 E3 is shown
in Fig. 6A. Controls included immunoblotting to verify the ex-
pression of two-hybrid fusions and also confirming that binding-
positive fusions did not stay positive in assays with one of two
fusions (e.g., SI Appendix, Fig. 6 A, 1). In agreement with
truncation-degradation assays (SI Appendix, Fig. S6), the in vivo
interaction between Ubr1 and the 527-residue Chk1 could be
abrogated by deleting the last 25 residues of Chk1 (Fig. 6A).
Mapping the Chk1 Degron by Split-Ubiquitin Binding Assays. In ad-
dition and independently, Ubr1–Chk1 interactions were also an-
alyzed by the split-Ub assay. In this method, test proteins are
expressed as fusions, respectively, to a C-terminal half of Ub (Cub)
and to its mutant N-terminal half (Nub). Interactions between test
proteins would reconstitute a quasi-native Ub moiety from Cub
and mutant Nub. The resulting cleavage of a Cub-containing fusion
by deubiquitylases downstream from the Ub moiety serves as a
readout of this technique (62, 63).














In agreement with truncation-degradation and two-hybrid as-
says (Fig. 6A and SI Appendix, Fig. S6), Ubr1 could bind, in split-
Ub assays, to the full-length SL-Chk11–527 but not to SL-Chk11–502
(SI Appendix, Figs. S4A and 6 B, 1 and 4). Moreover, the Ubr1-
recognized region of SL-Chk11–527 may be as small as 10 or fewer
C-terminal residues. Specifically, neither SL-Chk11–510 nor SL-
Chk11–517 could bind to Ubr1, in contrast to wild-type SL-Chk11–527
(Fig. 6B).
Degron-Specific Ubiquitylation of Chk1 in a Defined in Vitro System.
We also developed a ubiquitylation system that comprised the
following purified S. cerevisiae proteins: His6-Ub; the Uba1
E1 enzyme; the Rad6 E2 enzyme; the His6–Ubc4 E2 enzyme; the
C-terminally flag-tagged Ufd4f E3; the N-terminally flag-tagged
fUbr1 E3; the C-terminally myc–flag-tagged full-length SL-
Chk11−527m−f ; and also, alternatively, SL-Chk1
1−502
m−f , lacking the last
25 residues of Chk1 (Fig. 7A). This completely defined in vitro
system could reproduce the recognition of Chk1 by Ubr1 that
was inferred from truncation-degradation, two-hybrid, and split-
Ub assays (Fig. 6 A and B and SI Appendix, Fig. S6). SL-
Chk11−527m−f was polyubiquitylated if the system contained ATP,
Ub, Uba1, and at least Ubr1 and Rad6. Ufd4 and Ubc4 had no
effect in this system, and Ufd4–Ubc4 by themselves, in the ab-
sence of Ubr1, did not support polyubiquitylation of SL-
Chk11−527m−f (Fig. 7 B and C). Crucially, the complete system
containing SL-Chk11−502m−f , which lacked the 25 C-terminal resi-
dues of SL-Chk11−527m−f , could polyubiquitylate the latter but not
the former protein (Fig. 7C, lane 12).
In agreement with degron-mapping results (Figs. 6 A and B
and 7 and SI Appendix, Fig. S6), alignments of Chk1 amino acid
sequences from several yeasts (S. cerevisiae, Candida glabrata,
Lachancea fermentati, and Kluyveromyces lactis) revealed a par-
ticularly strong conservation of the last ∼25 residues, in com-
parison, e.g., with the next ∼30 residues upstream of that region
(Fig. 6D). The few divergences over the last 25 residues of
Chk1 involved solely changes to similar residues (Fig. 6D). In
sum, the minimal degron of SL-Chk11–527 comprises its ∼10 C-
terminal residues (Fig. 5B), but the complete degron is larger,
as suggested, in particular, by a weak but detectable Ubr1 de-
pendence of the degradation of SL-Chk11–502, which lacked the
last 25 residues of Chk1 (SI Appendix, Fig. S8B).
Chk1-Hsp90 Interactions in Wild-Type but Not in naa10Δ Cells.We found
that split-Ub assays (62, 63) could also detect in vivo interactions
between full-length Chk1 and Hsc82, the main Hsp90 chaperone
(Fig. 6 C, 1 and 2 and SI Appendix, Fig. S4 B, 3). This detection
required the absence of obstruction of the C terminus of the
Hsc82 moiety. Specifically, a split-Ub configuration in which the C
terminus of Hsc82 was linked to the Cub-activator moiety yielded a
barely detectable signal (SI Appendix, Fig. S4 B, 3 and 4), in
agreement with the importance of the C terminus of Hsc82, in-
cluding its dimerization and its interactions with cochaperones (8).
Remarkably, the same split-Ub assays that yielded a robust
Chk1–Hsc82 interaction signal in wild-type cells produced vir-
tually no interaction signal in naa10Δ cells (Fig. 6C and SI Ap-
pendix, Fig. S4C). This striking difference could not be caused by
a failure of the split-Ub assay itself, because the interactions
between Ubr1 and Chk1 were readily detected by split-Ub in
either wild-type or naa10Δ cells (SI Appendix, Fig. S4 B, 1 and 2).
The near-abrogation of the in vivo binding of Chk1 to its pro-
tector Hsc82 in naa10Δ cells (in contrast to wild-type cells) illu-
minated still another aspect of the impairment of the Hsp90 system
Fig. 5. Overexpression of the Arg/N-end rule pathway destabilizes Chk1. (A) CHX-chases, using PRT (Fig. 2B), with wild-type SL-Chk13f, for 0, 1, and 2 h, in wild-
type S. cerevisiae carrying a high-copy plasmid that expressed both flag-tagged Ubr1 (fUbr1) and Hsv-tagged Ufd4 (Ufd4hsv) from the bidirectional PGAL1,10
promoter. Lanes 2–4 and 5–7: cells containing the PGAL1,10-UBR1/UFD4 plasmid in glucose and galactose medium, respectively. Lanes 8–10 and 11–13 are as in lanes
2–4 and 5–7, respectively, but with cells containing a vector alone. The presence of fUbr1 and Ufd4hsv in lanes 5–7 was verified directly, using anti-flag and anti-Hsv
antibodies. Blue stars denote 20-, 25-, 37-, 50-, 75-, 100-, 150-, and 250-kDa markers. (B) Quantification of data in A. Rhombuses, squares, triangles, and crosses
denote, respectively, the decay curves of SL-Chk13f in wild-type cells overexpressing Ubr1-Ufd4 (in galactose), or containing vector alone (in glucose), or containing
the repressed Ubr1-Ufd4 plasmid (in glucose), or containing vector alone (in galactose). (C) Quantification of data in D, lanes 2–10. For curve designations, see the
keys below the immunoblot in D. (D) Lane 1, kDa markers. CHX-chase, using PRT (Fig. 2B), for 0, 1, and 2 h, with wild-type (lanes 2–4), naa10Δ (lanes 5–7), and
ubr1Δ (lanes 8–10) S. cerevisiae expressing Tyr–β-gal, derived from Ub–Tyr–β-gal. Lanes 11–19 are as in lanes 2–10 but with His–β-gal, derived from Ub–His–β-gal.
Blue stars indicate 37-, 50-, 75-, 100-, and 150-kDa markers. (E) Quantification of data in D, lanes 11–19. For curve designations, see the keys below the immu-
noblot in D. All chases in this study were performed at least twice, yielding results that differed by less than 10%.
E4376 | www.pnas.org/cgi/doi/10.1073/pnas.1705898114 Oh et al.
in the absence of NatA. The mechanism of this effect (Fig. 6C and
SI Appendix, Fig. S4C) remains to be understood. It may involve not
only Hsc82 and Hsp82, because both they and their ∼15 cochaper-
ones are either identified or predicted substrates of the NatA Nt-
acetylase that is absent in naa10Δ cells.
Discussion
This study revealed a major impairment of the Hsp90 chaperone
in naa10Δ S. cerevisiae, pinpointed causes of this perturbation,
showed that the Arg/N-end rule pathway is strongly up-regulated
in the absence of the NatA (Naa10) Nt-acetylase, identified
several substrates of the Arg/N-end rule pathway, and suggested
specific functions of Nt-acetylation in the physiological reg-
ulation of the Hsp90 system. In the absence of the NatA
Nt-acetylase, roughly 2,000 normally Nt-acetylated yeast proteins
lack this modification (45). In particular, the entire Hsp90 sys-
tem (Hsc82, Hsp82, and its ∼15 cochaperones) would not be
Nt-acetylated in naa10Δ cells (SI Appendix, Fig. S5).
One manifestation of Hsp90 impairment in naa10Δ cells was a
much faster degradation of Chk1 (a mitotic checkpoint kinase and
Hsp90 client) by the Arg/N-end rule pathway, which was found to
recognize a specific C terminus-proximal degron of Chk1 (Figs.
1B, 2, 6, and 7). The protection of Chk1 by Hsp90 could be
overridden not only by the absence of the NatA Nt-acetylase but
also by overexpression of the Arg/N-end rule pathway in wild-type
cells (Fig. 5 A and B). This result indicated that the rate of deg-
radation of Chk1 is determined by its dynamic partitioning be-
tween a protected Hsp90-bound state and a free state vulnerable
to the Arg/N-end rule pathway. Therefore it was possible that
the Arg/N-end rule pathway might be naturally up-regulated in
naa10Δ cells, because that upregulation would account, at least in
part, for the observed destabilization of Chk1 in these cells. The
Arg/N-end rule pathway was indeed found to be much more active
in naa10Δ cells than in wild-type cells (Figs. 3 B and C and 5 C–E).
Fig. 6. Mapping Chk1 degron by two-hybrid and split-ubiquitin assays.
(A) Two-hybrid binding assays with Ubr1 vs. Chk1. In both two-hybrid and split-Ub
assays, the expression of HIS3 (the ultimate readout of both assays), in
otherwise His− cells, was a function of affinity between test proteins. (A–C,
Left) Images of His-containing plates, on which all yeast strains grew. (Right)
His-lacking plates, on which only His+ cells grew. A two-hybrid-based Ubr1
fusion bearing the activation domain (AD) was examined vs. full-length
Chk11–527 and its truncated derivatives bearing the DNA-binding domain
(DBD). (A, 1) Ubr1 alone (negative control). (A, 2) Full-length Chk11–527 vs.
Ubr1. (A, 3) Chk11–502 vs. Ubr1. (A, 4) Chk11–465 vs. Ubr1. (B) Split-Ub binding
assays with Ubr1 vs. Chk1. Split-Ub–based fusions (Materials and Methods) of
Ubr1 vs. Chk11–527, Chk11–517, Chk11–510, and Chk11–502. (C) Split-Ub binding
assays with full-length Chk1 vs. full-length Hsc82 in wild-type, naa10Δ, and
naa10Δ ubr1Δ cells. C1, Chk1 alone (negative control). (D) Alignment of
C-terminal regions of Chk1 from the indicated yeast species. The last 25 resi-
dues of S. cerevisiae Chk1 are highlighted in yellow. The last 10 residues of
Chk1 (found to be essential for the binding to Ubr1; see C, 2) are marked as
well. Residues of Chk1 in species other than S. cerevisiae that differed from
those of S. cerevisiae Chk1 are in red.
Fig. 7. Degron-specific polyubiquitylation of Chk1 in a defined in vitro system.
(A) Coomassie-stained SDS/PAGE patterns of purified S. cerevisiae His6-Ub, Rad6,
His6-Ubc4, Ufd4f, full-length SL-Chk1
1−527
m−f , and fUbr1. (B) Lane 1, kDa markers.
Lanes 2–7, SL-Chk11−527m−f incubated in the presence of ATP, Ub, Uba1, and other
purified proteins as indicated. Immunoblotting with anti-flag antibody. (C) As in
B but independent Chk1 polyubiquitylation assays that included, in addition,
the assay with C-terminally truncated SL-Chk11−502m−f (lane 12).














Yet another result that revealed a distinct cause of Hsp90 im-
pairment in the absence of NatA was the degradation of Hsc82,
the main Hsp90 chaperone, by the Arg/N-end rule pathway in
naa10Δ cells and the corresponding (approximately twofold) de-
crease in the steady-state level of Hsc82+Hsp82 in the absence
NatA, relative to wild-type cells (Fig. 3 D and E and SI Appendix,
Fig. S7 C and D). The degradation of the Hsp90 chaperone
(Hsc82 and presumably Hsp82 as well) by the Arg/N-end rule
pathway in naa10Δ cells accounts, at least in part and in-
dependently of other causes, for the decreased protection of
Hsp90 clients under these conditions.
These and related results strongly suggested three causes of
the Hsp90 impairment in naa10Δ cells that are not mutually
exclusive. A fourth cause, also stated below, is hypothetical but
verifiable and would be physiologically important if correct.
i) A strongly increased activity of the Arg/N-end rule pathway
in the absence of NatA and, consequently, an increased
ability of this pathway to compete with Hsp90 for its clients
such as, for example, Chk1. This finding (Figs. 3 B and C,
and 5 C–E) provides a glimpse of still unexplored circuits
that regulate components of the Arg/N-end rule pathway
and its proteolytic activity.
ii) An intrinsic weakening of Hsp90 in naa10Δ cells, because
nearly all its components (Hsc82, Hsp82, and their ∼15
cochaperones) are NatA substrates (SI Appendix, Fig. S5).
The resulting impairment of protein interactions that normally
involve the Nt-Ac groups of Nt-acetylated proteins (see the
Introduction) is likely to underlie the observed degradation
of Hsp90 (Hsc82) by the Arg/N-end rule pathway in naa10Δ
cells (Fig. 3 D and E and SI Appendix, Figs. S4 D and E and
S5 C and D).
iii) In addition to a decreased steady-state level of the Hsc82
(Hsp90) protein in naa10Δ cells (see item ii above), one would
also expect the impairment of the Hsp90 system as a whole in
the absence of NatA. The functioning of Hsp90 involves its
transient binding to cochaperones, with some of them carrying
bound clients (12). Given the role of Nt-Ac groups in modu-
lating (usually enhancing) protein interactions within cognate
protein complexes (49), decreased affinities among most com-
ponents of the Hsp90 system, which are not Nt-acetylated in
naa10Δ cells, would be expected to perturb both the delivery
of clients to Hsp90 by cochaperones and other aspects of this
circuit, based on transient protein interactions.
Our detection, via split-Ub assays in wild-type cells, of the in
vivo interaction between Hsp90 (Hsc82) and its client Chk1 and
the remarkable near-ablation of this interaction in naa10Δ cells
(Fig. 6C and SI Appendix, Fig. S4B, 3 and 4) strongly support this
view of the Hsp90 system in cells lacking NatA.
iv) The absence of a normally present Nt-Ac group in a subunit of
a protein complex can decrease the subunit’s affinity for the
rest of the complex from ∼10-fold to ∼1,000-fold (48, 49).
Thus, the numerous and normally Nt-acetylated S. cerevisiae
proteins that lack this modification in naa10Δ cells would form
otherwise cognate in vivo complexes that would be prone to
(reversible) dissociation. Away from their natural protein li-
gands, at least some dissociated free subunits would be likely
to act as conformationally disordered Hsp90 clients, thereby
competing with normal Hsp90 clients and, consequently,
impairing protein homeostasis for that reason alone. Note that
some of these free proteins, dissociated from complexes that
would be less stable in naa10Δ cells, may even not require
assistance by Hsp90 cochaperones for binding to Hsp90.
(The fraction of in vivo Hsp90 clients that can interact with
Hsp90 directly, without their initial binding to cochaperones,
is not known.) This fourth mechanism of Hsp90 impairment in
naa10Δ cells remains to be addressed experimentally.
One feature of naa10Δ S. cerevisiae is the remarkably broad
range of this mutant’s abnormal phenotypes. They include cell-
cycle and mating defects as well as temperature sensitivity and
perturbations of protein synthesis and degradation (27, 46, 64).
Our finding of specific connections between the Hsp90-mediated
protein homeostasis and the Nt-acetylation of proteins by NatA
has revealed a major reason for the multiplicity of naa10Δ effects,
given the wide range of Hsp90 functions and their impairment in
the absence of NatA. Strong evolutionary conservation of the
Hsp90 system, Nt-acetylases, and N-end rule pathways indicates
that the results of this study are also relevant to multicellular
eukaryotes, including mammals.
Given the advances described above, an important question is
whether a perturbation of the Hsp90 system that is similar to the
impairment observed with naa10Δ S. cerevisiae can also occur in
nonmutational settings. Decreased NatA activity can be caused,
for example, by a stress-mediated down-regulation of Ac-CoA,
the co-substrate of Nt-acetylases. Indeed, physiologically rele-
vant changes in the levels of Ac-CoA have been shown to affect
both the efficacy of Nt-acetylation and the sensitivity of mam-
malian cells to apoptotic signals (65). It would be illuminating,
therefore, to determine a role that the Hsp90 system plays in
specific connections between Ac-CoA, Nt-acetylation, and apo-
ptosis, particularly because the Arg/N-end rule pathway has al-
ready been shown to be a regulator of apoptosis (22, 29).
Changes in the rate of Nt-acetylation of cellular proteins by NatA
can also be caused by altered levels of the NatA Nt-acetylase and/or
changes in its enzymatic activity. The expression of NatA in the plant
Arabidopsis thaliana and, correspondingly, the in vivo Nt-acetylation
of NatA substrates have been found to be controlled by the phy-
tohormone abscisic acid (66). Remarkably, a natural decrease of
NatA during drought was shown to be required for plants’ tolerance
to drought (66). Analogous regulated changes in the levels of NatA
and/or Ac-CoA, as well as connections between these changes and
either the Hsp90 system or the Arg/N-end rule pathway, remain to
be explored in other organisms, including mammals.
Materials and Methods
For further information, see SI Appendix, SI Materials and Methods.
Yeast Strains, Media, and Genetic Techniques. The S. cerevisiae strains used in
this work are described in SI Appendix, Table S1. Standard techniques were
used for strain construction and transformation. S. cerevisiae media included
yeast extract/peptone/dextrose (YPD) and Synthetic Complete (SC) medium
(Sigma-Aldrich).
Construction of Plasmids. The plasmids used in this study are described in SI
Appendix, Table S2. Construction details are described in SI Appendix, SI Ma-
terials and Methods. All final constructs were verified by DNA sequencing.
PRT-Based CHX-Chases, Tc-Chases, and 35S-Pulse-Chase Assays. The PRT method
is described in Fig. 2 A and B. Details of PRT-based CHX-chases and Tc-chases
are described in SI Appendix, SI Materials and Methods. Protein bands vi-
sualized by immunoblotting were quantified using an Odyssey-9120 Imaging
System (LI-COR).
Two-Hybrid Assays. Yeast-based two-hybrid binding assays (61) were carried out
largely as described previously (21). “AD” and “DBD” refer to activation domain
and DNA-binding domain, respectively. In both two-hybrid and split-Ub assays
(described below), the expression of HIS3 (the ultimate readout of both assays),
in otherwise His− cells, was a function of affinity between test proteins.
Split-Ub Assays. Yeast-based split-Ub binding assays (62, 63) were carried out
largely as described previously (21).
In Vitro Ubiquitylation Assay. Protein components of the assay were expressed
in Escherichia coli or S. cerevisiae. The assay was carried as described in SI
Appendix, SI Materials and Methods.
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